Equitable Community Access to Pharmacist Services Act
- Bill Number
- S. 2426
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-07-24: Read twice and referred to the Committee on Finance. (text: CR S4701)
- Last Updated
- 2026-06-17T11:03:25Z
AI-Generated Summary
Purpose
The Equitable Community Access to Pharmacist Services Act aims to expand Medicare Part B coverage to include certain diagnostic and treatment services provided by pharmacists. This legislation seeks to improve access to care for common illnesses and public health emergencies by allowing pharmacists to deliver services that are typically handled by physicians, particularly in community settings.
Key Provisions
- Coverage of Pharmacist Services: Amends Section 1861 of the Social Security Act to add "pharmacist services" as a covered benefit under Medicare Part B. These services include evaluation, management, testing, or treatment for specific conditions such as COVID-19, influenza, respiratory syncytial virus (RSV), or streptococcal pharyngitis (strep throat). Coverage also extends to services addressing public health needs during emergencies declared under federal law (Section 319 of the Public Health Service Act).
- Requirements for Services: Pharmacists must be legally authorized under state law to provide these services. If state law requires supervision or collaboration with a physician or other qualified healthcare provider (defined in the law as certain practitioners), the services must meet those standards. "Collaboration" is defined as pharmacists working with physicians using jointly developed guidelines or state-defined mechanisms, with appropriate medical direction and supervision.
- Payment Structure: Establishes payment under Medicare Part B at 80% of the lesser of the actual charge or 85% of the fee determined under the physician fee schedule (Section 1848). For services tied to public health emergencies, payment can reach 100% of the fee schedule amount.
- Balance Billing Prohibition: Prevents pharmacists from charging Medicare beneficiaries more than the approved amount (similar to rules for physicians), ensuring patients pay only their deductible or coinsurance.
- Effective Date: Applies to services provided on or after January 1, 2026.
Significant Changes to Existing Law
- Expansion of Covered Providers: Previously, Medicare Part B coverage for evaluation and management services was primarily limited to physicians and certain practitioners. This bill explicitly includes pharmacists for targeted services, broadening the types of providers eligible for reimbursement.
- Integration with State Laws: Introduces requirements that align federal coverage with varying state regulations on pharmacist scope of practice, which could standardize but also depend on state-specific rules for supervision or collaboration.
- Adjusted Payment Rates: Introduces a new payment tier for pharmacist services, set at a discount (85% or 100%) from the standard physician fee schedule, differing from the full rates typically applied to physician services.
Potential Impacts
- On Citizens (Medicare Beneficiaries): Increases access to convenient, community-based testing and treatment for common respiratory illnesses and public health threats, potentially reducing the need for physician visits or emergency room trips, especially in rural or underserved areas with limited doctor availability.
- On Government Agencies: The Centers for Medicare & Medicaid Services (CMS) will need to update payment systems, develop guidelines for eligible services, and coordinate with states to verify compliance with local laws, which may require additional administrative resources.
- On International Relations: No direct impacts, as the bill focuses on domestic Medicare policy.
Main Stakeholders Affected
- Pharmacists and Pharmacies: Gain new reimbursement opportunities under Medicare, potentially expanding their role in primary care delivery.
- Medicare Beneficiaries: Benefit from broader access to affordable services but may face changes in how they receive care.
- Physicians and Healthcare Providers: Could see reduced workload for routine cases but must collaborate with pharmacists where required by state law.
- State Governments: Involved through enforcement of their laws on pharmacist practice, potentially influencing how services are implemented locally.
- CMS and Federal Agencies: Responsible for oversight, payments, and defining public health emergency-related services.
Notable Legal, Constitutional, or Political Implications
- Legal Implications: Reinforces federal deference to state authority on healthcare provider scopes (e.g., supervision rules), which could lead to variations in implementation across states and potential future litigation if state-federal alignments are challenged. The balance billing prohibition strengthens patient protections under Medicare.
- Constitutional Implications: No apparent conflicts with constitutional principles, as it operates within Congress's authority to regulate interstate commerce and social welfare programs like Medicare.
- Political Implications: Bipartisan support (introduced by senators from both parties) highlights a consensus on improving healthcare access amid ongoing public health concerns. It may encourage further expansions of non-physician provider roles, influencing debates on workforce shortages and cost control in healthcare.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (31)
Sen. Warner, Mark R. [D-VA], Sen. Tillis, Thomas [R-NC], Sen. Daines, Steve [R-MT], Sen. Hassan, Margaret Wood [D-NH], Sen. Warren, Elizabeth [D-MA], Sen. Welch, Peter [D-VT], Sen. Cortez Masto, Catherine [D-NV], Sen. Lankford, James [R-OK], Sen. Blunt Rochester, Lisa [D-DE], Sen. Cramer, Kevin [R-ND], Sen. Klobuchar, Amy [D-MN], Sen. Sullivan, Dan [R-AK], Sen. Heinrich, Martin [D-NM], Sen. Shaheen, Jeanne [D-NH], Sen. Capito, Shelley Moore [R-WV], Sen. Fischer, Deb [R-NE], Sen. Murkowski, Lisa [R-AK], Sen. Kaine, Tim [D-VA], Sen. Coons, Christopher A. [D-DE], Sen. Rounds, Mike [R-SD], Sen. Schiff, Adam B. [D-CA], Sen. Kennedy, John [R-LA], Sen. Mullin, Markwayne [R-OK], Sen. Marshall, Roger [R-KS], Sen. Blackburn, Marsha [R-TN], Sen. Peters, Gary C. [D-MI], Sen. Whitehouse, Sheldon [D-RI], Sen. Collins, Susan M. [R-ME], Sen. Murray, Patty [D-WA], Sen. McCormick, David [R-PA], Sen. Merkley, Jeff [D-OR]
Recent Actions
- 2025-07-24: Read twice and referred to the Committee on Finance. (text: CR S4701)
- 2025-07-24: Introduced in Senate
Bill Versions
- Equitable Community Access to Pharmacist Services Act — issued 2025-07-24 — PDF (5 pages)